Affinity Asset Advisors, LLC
NEW YORK NY · SEC CIK 0001773195
$19.36亿2026Q1 申报市值
105持仓数
41.6%前十大占比 · 第一大 6.7%
28 / 18新建仓 / 清仓
26Q126Q2
前十大持仓 占组合比例
2026Q1 买入最多 按季末市值估算
CENTESSA PHARMAC 加仓+$3,175.41万
ROIV 加仓+$3,047.00万
ANAB 加仓+$2,746.98万
XENE 加仓+$2,471.38万
ERAS 加仓+$2,346.10万
2026Q1 卖出最多 按季末市值估算
VENTYX BIOSCIENC 清仓-$5,855.56万
ARCELLX INC 减仓-$1,848.15万
CGEM 减仓-$1,635.35万
ORKA 减仓-$1,484.59万
BBIO 减仓-$1,262.42万
2026Q1 持仓明细 点表头排序 · 每页 100 行
导出 CSV 🔒| 代码 | 名称 | 市值 ▲ | 占比 | 股数 | 变动股数 | 变动 | 估算买卖额 | 操作 |
|---|---|---|---|---|---|---|---|---|
| — | FORTE BIOSCIENCES INC | $2,620.80万 | 1.35% | 1,011,890 | 22,400 | 2.3% | $58.02万 | 加仓 |
| STRO | SUTRO BIOPHARMA INC | $2,664.17万 | 1.38% | 1,069,519 | 321,137 | 42.9% | $799.95万 | 加仓 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | $2,879.09万 | 1.49% | 55,000 | 23,869 | 76.7% | $1,249.47万 | 加仓 |
| COGT | COGENT BIOSCIENCES INC | $2,886.75万 | 1.49% | 750,000 | 400,000 | 114.3% | $1,539.60万 | 加仓 |
| LXEO | LEXEO THERAPEUTICS INC | $2,898.82万 | 1.50% | 5,050,211 | 1,850,211 | 57.8% | $1,062.02万 | 加仓 |
| DNTH | DIANTHUS THERAPEUTICS INC | $2,937.20万 | 1.52% | 350,000 | 235,000 | 204.3% | $1,972.12万 | 加仓 |
| — | TERNS PHARMACEUTICALS INC | $2,966.19万 | 1.53% | 562,631 | 12,631 | 2.3% | $66.59万 | 加仓 |
| — | NUVALENT INC | $3,073.50万 | 1.59% | 300,000 | -22,633 | -7.0% | -$231.88万 | 减仓 |
| MRNA | MODERNA INC 看涨期权 | $4,064.00万 | 2.10% | 800,000 | 800,000 | — | $4,064.00万 | 新建仓 |
| — | ARCELLX INC | $4,165.26万 | 2.15% | 362,764 | -160,961 | -30.7% | -$1,848.15万 | 减仓 |
| — | TEVA PHARMACEUTICAL INDS LTD | $4,216.80万 | 2.18% | 1,400,000 | 0 | 0.0% | — | 不变 |
| ABVX | ABIVAX SA | $4,509.68万 | 2.33% | 405,000 | -100,000 | -19.8% | -$1,113.50万 | 减仓 |
| CYTK | CYTOKINETICS INC | $4,616.88万 | 2.38% | 700,483 | -99,517 | -12.4% | -$655.92万 | 减仓 |
| ALKS | ALKERMES PLC | $4,773.60万 | 2.47% | 1,350,000 | 350,000 | 35.0% | $1,237.60万 | 加仓 |
| ANAB | ANAPTYSBIO INC | $5,213.24万 | 2.69% | 940,000 | 495,308 | 111.4% | $2,746.98万 | 加仓 |
| PRAX | PRAXIS PRECISION MEDICINES I | $5,477.23万 | 2.83% | 170,000 | -15,000 | -8.1% | -$483.29万 | 减仓 |
| — | CENTESSA PHARMACEUTICALS PLC | $5,560.80万 | 2.87% | 1,400,000 | 799,448 | 133.1% | $3,175.41万 | 加仓 |
| SYRE | SPYRE THERAPEUTICS INC | $6,451.95万 | 3.33% | 1,279,134 | -153,457 | -10.7% | -$774.04万 | 减仓 |
| ROIV | ROIVANT SCIENCES LTD | $7,756.00万 | 4.01% | 2,800,000 | 1,100,000 | 64.7% | $3,047.00万 | 加仓 |
| INSM | INSMED INC | $7,848.96万 | 4.05% | 480,000 | 30,000 | 6.7% | $490.56万 | 加仓 |
| ERAS | ERASCA INC | $8,656.30万 | 4.47% | 5,350,000 | 1,450,000 | 37.2% | $2,346.10万 | 加仓 |
| XENE | XENON PHARMACEUTICALS INC | $9,740.12万 | 5.03% | 1,675,000 | 425,000 | 34.0% | $2,471.38万 | 加仓 |
| — | APOGEE THERAPEUTICS INC | $1.08亿 | 5.59% | 1,284,926 | 50,000 | 4.0% | $420.85万 | 加仓 |
| SPY | STATE STR SPDR S&P 500 ETF T 看跌期权 | $1.30亿 | 6.72% | 200,000 | 200,000 | — | $1.30亿 | 新建仓 |